{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:20:54Z","timestamp":1787779254522,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hlc.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:51:00Z","timestamp":1787777460000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infectious Diseases and Pulmonary Arterial Hypertension: A Review"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8731-689X","authenticated-orcid":false,"given":"C\u00e1ssia","family":"da Luz Goulart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela Martina Bohns","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldair Darlan","family":"Santos-de-Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Bellon dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Brum","family":"Spilimbergo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Vit\u00f3ria","family":"Alves dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Peixoto Tinoco","family":"Ar\u00eaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Almeida-Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2026.06.015_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"Suppl","key":"10.1016\/j.hlc.2026.06.015_bib2","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2026.06.015_bib58","doi-asserted-by":"crossref","first-page":"2401222","DOI":"10.1183\/13993003.01222-2024","article-title":"The Seventh World Symposium on pulmonary hypertension: our journey to Barcelona","volume":"64","author":"Humbert","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2026.06.015_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/ers.11.10","article-title":"HIV infection and pulmonary arterial hypertension","volume":"5","author":"Cicalini","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/COH.0000000000000418","article-title":"HIV-associated pulmonary hypertension","volume":"12","author":"Jarrett","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.hlc.2026.06.015_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108026","article-title":"Schistosomiasis-associated pulmonary arterial hypertension (Sch-PAH): a comprehensive review of diagnosis and management","volume":"240","author":"Pata","year":"2025","journal-title":"Respir Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib6","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary arterial hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2026.06.015_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0046-8177(87)80417-3","article-title":"Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome","volume":"18","author":"Kim","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hlc.2026.06.015_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCULATIONAHA.114.006978","article-title":"Human immunodeficiency virus-associated pulmonary arterial hypertension: considerations for pulmonary vascular diseases in the developing world","volume":"131","author":"Butrous","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2026.06.015_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/903454","article-title":"Human immunodeficiency virus and pulmonary arterial hypertension","volume":"2013","author":"Mirrakhimov","year":"2013","journal-title":"ISRN Cardiol"},{"key":"10.1016\/j.hlc.2026.06.015_bib13","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.3390\/ijms21093305","article-title":"The DNA damage response and HIV-associated pulmonary arterial hypertension","volume":"21","author":"Simenauer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hlc.2026.06.015_bib14","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.3390\/jcm12103425","article-title":"Pulmonary arterial hypertension associated with portal hypertension and HIV infection: comparative characteristics and prognostic predictors","volume":"12","author":"Dardi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1468-1293.2010.00829.x","article-title":"HIV and pulmonary arterial hypertension: a systematic review","volume":"11","author":"Janda","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/aid.2012.0166","article-title":"High prevalence of pulmonary arterial hypertension in a cohort of asymptomatic HIV-infected patients","volume":"29","author":"Isasti","year":"2013","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.hlc.2026.06.015_bib17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.201006-0836OC","article-title":"HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era","volume":"183","author":"Crothers","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl","key":"10.1016\/j.hlc.2026.06.015_bib18","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1378\/chest.09-3065","article-title":"Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective","volume":"137","author":"Almodovar","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2026.06.015_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020971518","article-title":"Prevalence and risk factors of pulmonary hypertension among adult patients with HIV infection in Ethiopia","volume":"10","author":"Huluka","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2026.06.015_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib21","article-title":"To estimate prevalence of pulmonary arterial hypertension in HIV patients and its association with CD4 cell count","volume":"25","author":"Mahajan","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.hlc.2026.06.015_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-related pulmonary hypertension: analytic review of 131 cases","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2026.06.015_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/QAD.0b013e328354f5a1","article-title":"Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up","volume":"26","author":"Quezada","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.hlc.2026.06.015_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa035115","article-title":"Expression of human herpesvirus 8 in primary pulmonary hypertension","volume":"349","author":"Cool","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2010.03286.x","article-title":"Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach","volume":"17","author":"Cicalini","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.hlc.2026.06.015_bib27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000097495","article-title":"Absence of human herpesvirus 8 DNA sequences in lung biopsies from Israeli patients with pulmonary arterial hypertension","volume":"75","author":"Bendayan","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.hlc.2026.06.015_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e3282f7cd42","article-title":"Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension","volume":"22","author":"Hsue","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.hlc.2026.06.015_bib30","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3201\/eid1109.040880","article-title":"Human herpesvirus 8 and pulmonary hypertension","volume":"11","author":"Nicastri","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.hlc.2026.06.015_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1183\/09031936.03.00006903","article-title":"Primary pulmonary hypertension, Castleman\u2019s disease and human herpesvirus-8","volume":"22","author":"Bull","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2026.06.015_bib32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1165\/rcmb.2014-0045TR","article-title":"The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox","volume":"51","author":"Voelkel","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.hlc.2026.06.015_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13468","article-title":"Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 years of evidence from the REHAP registry","volume":"292","author":"Salvador","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2022.08.813","article-title":"Infections and cardiovascular disease: JACC focus Seminar 1\/4","volume":"81","author":"Farina","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2026.06.015_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1556\/1886.2024.00013","article-title":"Insights into the epidemiology, pathogenesis, and differential diagnosis of schistosomiasis","volume":"14","author":"Ponzo","year":"2024","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"10.1016\/j.hlc.2026.06.015_bib36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1378\/chest.11-0483","article-title":"The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension","volume":"141","author":"Fernandes","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2026.06.015_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0089-2019","article-title":"Schistosomiasis-associated pulmonary arterial hypertension: a systematic review","volume":"29","author":"Knafl","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.hlc.2026.06.015_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","article-title":"The global status of schistosomiasis and its control","volume":"77","author":"Chitsulo","year":"2000","journal-title":"Acta Trop"},{"issue":"Suppl","key":"10.1016\/j.hlc.2026.06.015_bib39","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2026.06.015_bib40","article-title":"Schistosomiasis-associated pulmonary arterial hypertension: survival in endemic area in Brazil","volume":"25","author":"Piscoya Roncal","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.hlc.2026.06.015_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1378\/chest.14-1036","article-title":"Pulmonary arterial hypertension in the Southern Hemisphere: results from a registry of incident Brazilian cases","volume":"147","author":"Alves","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2026.06.015_bib42","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.chest.2015.09.018","article-title":"Severe pulmonary arterial hypertension in patients treated for hepatitis C with sofosbuvir","volume":"149","author":"Renard","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2026.06.015_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tim.2003.12.005","article-title":"Pathophysiology of hepatitis C virus infection and related liver disease","volume":"12","author":"Pawlotsky","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.hlc.2026.06.015_bib44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1086\/678507","article-title":"Schistosomiasis-associated pulmonary hypertension","volume":"4","author":"Papamatheakis","year":"2014","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2026.06.015_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0104-42302006000300012","article-title":"Caracter\u00edsticas cl\u00ednicas dos pacientes com hipertens\u00e3o pulmonar em dois centros de refer\u00eancia em S\u00e3o Paulo","volume":"52","author":"Lapa","year":"2006","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.hlc.2026.06.015_bib46","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1513\/AnnalsATS.201405-225OC","article-title":"Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus\u2013hepatitis C virus coinfection","volume":"11","author":"Sangal","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.hlc.2026.06.015_bib47","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MCP.0000000000000300","article-title":"Pulmonary arterial hypertension in schistosomiasis","volume":"22","author":"Gavilanes","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2023.100007","article-title":"Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?","volume":"1","author":"Graham","year":"2023","journal-title":"JHLT Open"},{"key":"10.1016\/j.hlc.2026.06.015_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75290-4","article-title":"HIV- and HCV-specific markers and echocardiographic pulmonary artery systolic pressure among United States veterans","volume":"10","author":"Zola","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.hlc.2026.06.015_bib50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3389\/fimmu.2016.00662","article-title":"Host and viral modulation of RIG-I-mediated antiviral immunity","volume":"7","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.hlc.2026.06.015_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001517","article-title":"Portopulmonary hypertension: an updated review","volume":"9","author":"Jasso-Baltazar","year":"2023","journal-title":"Transplant Direct"},{"key":"10.1016\/j.hlc.2026.06.015_bib52","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01634-2020","article-title":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?","volume":"56","author":"Huertas","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2026.06.015_bib53","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1513\/AnnalsATS.202008-1014ED","article-title":"COVID-19 and pulmonary arterial hypertension: early data and many questions","volume":"17","author":"Farha","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.hlc.2026.06.015_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1023758","article-title":"From acute SARS-CoV-2 infection to pulmonary hypertension","volume":"13","author":"Eroume \u00c0 Egom","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.hlc.2026.06.015_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43168-023-00201-w","article-title":"Study of pulmonary hypertension in post-COVID-19 patients by transthoracic echocardiography","volume":"17","author":"Taha","year":"2023","journal-title":"Egypt J Bronchol"},{"key":"10.1016\/j.hlc.2026.06.015_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(24)00295-9","article-title":"Global, regional, and national burden of pulmonary arterial hypertension, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"13","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hlc.2026.06.015_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2024.1442626","article-title":"The World Health Organization\u2019s Rehabilitation 2030 vision: an African perspective","volume":"5","author":"Douryang","year":"2024","journal-title":"Front Rehabil Sci"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626004713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626004713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:51:08Z","timestamp":1787777468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950626004713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S1443950626004713"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2026.06.015","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious Diseases and Pulmonary Arterial Hypertension: A Review","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}